BOULDER, Colo., May 29, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.